Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Array BioPharma identifies new protein kinase inhibitors

July 24, 2020

Novartis reports first-in-human data for BLZ-945

July 24, 2020

Fe-isty cancer cells flourish in hostile subarachnoid space

July 24, 2020

CStone Pharmaceuticals presents data on the CDK4/6 inhibitor CS-3002

July 24, 2020

Janpix describes small-molecule monovalent STAT3 and STAT5 protein degraders

July 24, 2020

Gan & Lee opens phase Ib/II study of GLR-2007 in advanced solid tumors

July 23, 2020

Janssen Pharmaceutica and Johnson & Johnson present FGFR3 inhibitors

July 23, 2020

Integral BioSciences discloses IDH1 mutant inhibitors

July 23, 2020

SPV Therapeutics synthesizes new CDK inhibitors

July 23, 2020

CSF-1R as novel therapeutic target in 4T1 xenografts

July 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...